Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

WOUNDCOM

Financiado

Cerrado

Interactive biomembranes for wound management exploiting the unique wound heal...

Interactive biomembranes for wound management exploiting the unique wound healing and antimicrobial properties of human collagen VI This project's objective is to develop a wound dressing product that will address the unmet needs of patients with chronic wounds. The prevalence of chronic wounds is increasing and results in a growing utilization of healthcare a... ver más

31/01/2019

COLZYX AB

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

COLZYX AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-01-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

COLZYX AB

50.00K€ | Lider

EKOTEK INGENIERIA Y CONSULTO...

527.89K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

WOUNDCOM The first bioactive wound dressing exploiting the unique w... 4M€ Cerrado

NATURALSKIN Rapid absorption denaturalized collagen dressings 71K€ Cerrado

MIMESIS Development of biomaterials through mimesis of plant defensi... 2M€ Cerrado

BIOCURE Novel Biomaterial for Improved and Cost efficient Wound Heal... 2M€ Cerrado

MULTIZONAL SCAFFOLD Multizonal scaffold system based on collagen and copper dope... 171K€ Cerrado

PDC2021-121405-I00 ADAPTACION Y VALIDACION DEL PROCESO DE FABRICACION DE APOSIT... 144K€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2018-07-13
Fecha Fin: 2019-01-31

Líder del proyecto

COLZYX AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto This project's objective is to develop a wound dressing product that will address the unmet needs of patients with chronic wounds. The prevalence of chronic wounds is increasing and results in a growing utilization of healthcare and financial resources. The available wound care options can manipulate one or multiple aspects of the wound environment, but cannot form antibacterial barriers and facilitate healing to a satisfactory level at the same time. Colzyx aims to address this challenge by developing an innovative wound dressing product that will make use of the newlydiscovered healing and antimicrobial properties of human collagen VI. It is first-in-class product which uses highly functional molecules from the human innate immune system in wound management. This novel technology combines these potent molecules with a biomembrane – established in wound management market. Together, they effectively enhance wound closure and fight bacterial infection simultaneously. This approach offers significant benefits to patients by reducing pain and discomfort, and accelerating recovery. It will also shorten hospitalisation time and decrease labour for healthcare professionals and the financial burden. Comparing to available wound dressings, Colzyx’s product is unique and will address a new market category of interactive biomembranes. The ultimate success will depend on the quality of confirmatory data and agreement with development partner to share the challenges of subsequent research and market introduction. Colzyx plans to take the product through the CE-mark registration study and reach the market through an agreement with a strong defined licence partner. The problem of pathogenic resistance to drugs is growing and highlighted by the national and international health organisations. This adds to the significance of the challenge posed by chronic wounds and ensures Colzyx in the endeavour of developing and bringing to the market its novel wound dressing.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores